Macerich shares remain entrenched in a persistent downward trajectory, creating a puzzling disconnect for investors. Despite the company reporting robust operational performance in its latest quarterly results, equity markets continue to express skepticism through persistent selling pressure.
Strong Leasing Activity Fails to Impress Investors
The third quarter of 2025 revealed impressive operational metrics for Macerich. The real estate investment trust reported funds from operations (FFO) of $0.35 per share and demonstrated remarkable leasing momentum. During the quarter, the company signed leases covering 1.5 million square feet for both new and renewed agreements, representing an 87 percent surge compared to the same period last year.
The leasing strength becomes even more apparent when examining year-to-date figures. Through September 2025, total leasing volume reached 5.4 million square feet, marking an 86 percent increase. Occupancy rates remained stable at a healthy 94.3 percent, yet these positive operational developments have failed to translate into share price appreciation.
Dividend Declaration Overshadowed by Technical Weakness
On October 30, 2025, Macerich announced a quarterly dividend distribution of $0.17 per share, scheduled for payment on December 29, 2025. While this news would typically appeal to income-focused REIT investors, market reaction tells a different story:
Should investors sell immediately? Or is it worth buying Macerich?
- Latest trading session: Decline of 0.67% to $17.90
- Two-week performance: Down 0.56%
- Current session forecast: Additional 1.22% drop anticipated
Technical analysis clearly indicates the security remains trapped in a bearish trend pattern, with the dividend announcement providing insufficient momentum to reverse sentiment.
Strategic Debt Reduction Initiative Faces Scrutiny
Management has initiated an ambitious deleveraging strategy dubbed the “Path Forward” program. This initiative aims to generate $2 billion through the disposition of shopping center assets by the end of 2026. The primary objective involves improving the company’s leverage ratio, with the current net debt to EBITDA multiple standing at 7.76x.
The critical question remains whether these strategic measures will convince wary market participants. Analyst consensus currently reflects caution, maintaining a “Hold” rating with an average price target of $19.58. This represents a sobering assessment given the underlying operational strength demonstrated in recent reporting periods.
Market observers continue to monitor whether the company’s fundamental performance will eventually manifest in share price recovery, or if persistent investor skepticism indicates concerns not immediately apparent in quarterly financial statements.
Ad
Macerich Stock: Buy or Sell?! New Macerich Analysis from November 14 delivers the answer:
The latest Macerich figures speak for themselves: Urgent action needed for Macerich investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 14.
Macerich: Buy or sell? Read more here...










